These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26183634)

  • 1. Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: report of a case.
    Matsuda D; Toshima T; Ikegami T; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Clin J Gastroenterol; 2014 Apr; 7(2):159-63. PubMed ID: 26183634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombotic microangiopathy after living-donor liver re-transplantation.
    Matsusaki T; Morimatsu H; Sato T; Sato K; Mizobuchi S; Morita K
    J Anesth; 2010 Aug; 24(4):614-7. PubMed ID: 20458598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombotic microangiopathy after living-donor liver transplantation.
    Shindoh J; Sugawara Y; Akamatsu N; Kaneko J; Tamura S; Yamashiki N; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N
    Am J Transplant; 2012 Mar; 12(3):728-36. PubMed ID: 22070669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombotic microangiopathy-like disorder after living-donor liver transplantation: a single-center experience in Japan.
    Hori T; Kaido T; Oike F; Ogura Y; Ogawa K; Yonekawa Y; Hata K; Kawaguchi Y; Ueda M; Mori A; Segawa H; Yurugi K; Takada Y; Egawa H; Yoshizawa A; Kato T; Saito K; Wang L; Torii M; Chen F; Baine AM; Gardner LB; Uemoto S
    World J Gastroenterol; 2011 Apr; 17(14):1848-57. PubMed ID: 21528059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.
    Motomura T; Yoshizumi T; Ohira M; Mano Y; Toshima T; Itoh S; Harada N; Harimoto N; Ikegami T; Soejima Y; Maehara Y
    Transplant Proc; 2017 Dec; 49(10):2409-2410. PubMed ID: 29198692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Incidence of Thrombotic Microangiopathy After ABO-Incompatible Living Donor Liver Transplantation.
    Kishida N; Shinoda M; Itano O; Obara H; Kitago M; Hibi T; Yagi H; Abe Y; Matsubara K; Odaira M; Tanabe M; Shimazu M; Kitagawa Y
    Ann Transplant; 2016 Dec; 21():755-764. PubMed ID: 27956735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Von Willebrand Factor Deposition and ADAMTS-13 Consumption in Allograft Tissue of Thrombotic Microangiopathy-like Disorder After Living Donor Liver Transplantation: A Case Report.
    Nakanuma S; Miyashita T; Hayashi H; Ohbatake Y; Takamura H; Okazaki M; Yamaguchi T; Sakai S; Makino I; Oyama K; Tajima H; Ninomiya I; Fushida S; Ohta T
    Transplant Proc; 2017 Sep; 49(7):1596-1603. PubMed ID: 28651806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased ADAMTS13 levels in patients after living donor liver transplantation.
    Kobayashi T; Wada H; Usui M; Sakurai H; Matsumoto T; Nobori T; Katayama N; Uemoto S; Ishizashi H; Matsumoto M; Fujimura Y; Isaji S
    Thromb Res; 2009 Nov; 124(5):541-5. PubMed ID: 19423151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report.
    Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B
    BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The outcomes of thrombotic microangiopathy after liver transplantation: A nationwide survey in Japan.
    Takatsuki M; Eguchi S; Yamamoto M; Yamaue H; Takada Y;
    J Hepatobiliary Pancreat Sci; 2022 Feb; 29(2):282-292. PubMed ID: 34355533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy in living-donor liver transplantation.
    Tamura S; Sugawara Y; Matsui Y; Kishi Y; Akamatsu N; Kaneko J; Makuuchi M
    Transplantation; 2005 Jul; 80(2):169-75. PubMed ID: 16041260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy.
    Nishi H; Hanafusa N; Kondo Y; Nangaku M; Sugawara Y; Makuuchi M; Noiri E; Fujita T
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):811-9. PubMed ID: 17699291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation.
    Takahashi N; Wada H; Usui M; Kobayashi T; Habe-Ito N; Matsumoto T; Uemoto S; Nobori T; Isaji S
    Thromb Res; 2013 Mar; 131(3):225-9. PubMed ID: 23266519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation.
    Miyata R; Shimazu M; Tanabe M; Kawachi S; Hoshino K; Wakabayashi G; Kawai Y; Kitajima M
    Liver Transpl; 2007 Oct; 13(10):1455-62. PubMed ID: 17902122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage liver cirrhosis with severe autoimmune hemolytic anemia, treated by blood type-incompatible living donor liver transplantation: a case report.
    Sanefuji K; Ikegami T; Nagata S; Sugimachi K; Gion T; Uchiyama H; Soejima Y; Taketomi A; Shirabe K; Maehara Y
    Transplant Proc; 2011 Jun; 43(5):2087-9. PubMed ID: 21693332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic Microangiopathy Following Pediatric Autologous Hematopoietic Cell Transplantation: A Report of Significant End-Organ Dysfunction in Eculizumab-Treated Survivors.
    Schoettler M; Lehmann L; Li A; Ma C; Duncan C
    Biol Blood Marrow Transplant; 2019 May; 25(5):e163-e168. PubMed ID: 30639820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic microangiopathy after ABO-incompatible living donor liver transplantation: a case report.
    Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Watanabe T; Kokai H; Hatakeyama K
    Transplant Proc; 2008 Oct; 40(8):2549-51. PubMed ID: 18929797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.
    Shochet L; Kanellis J; Simpson I; Ta J; Mulley W
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.